Allergan CEO: Merger with Pfizer was targeted by US government

by Bill Fester on April 6, 2016

in Pharmaceutical

Allergan CEO Brent Saunders told CNBC on Wednesday the U.S. government had targeted his company’s failed $160 billion deal with Pfizer.

“It really looked like they did a very fine job of constructing a rule here — a temporary rule — to stop this deal, and obviously it was successful,” he told CNBC’s “Squawk on the Street.”

See the rest of the story (plus video)



Previous post:

Next post: